Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Regular treatment of functional constipation

PreclinicalSmall molecule

XXijing Hospital of Digestive Diseases

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2026

Constipation

NCT06221722

Clinical

Trials by Indication[1]

Constipation1 trial

Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation

Recruiting·XXijing Hospital of Digestive Diseases··NCT06221722·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Regular treatment of functional constipation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Regular treatment of functional constipation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Regular treatment of functional constipation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Xijing Hospital of Digestive Diseases company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: XXijing Hospital of Digestive Diseases

Related News